Enovis ENOV Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Prevention & Recovery | $272.02M-0.2% | —— | —— | —— | $272.58M— | |
| Reconstructive | $317.13M+10.8% | $292.88M+6.9% | $257.97M+11.7% | $273.98M+10.7% | $286.25M+11.3% | |
| Adjusted EBITDA (non-GAAP) by Business | ||||||
| Prevention & Recovery | $31.11M+0.7% | —— | —— | —— | $30.9M— | |
| Reconstructive | $72.46M+6.1% | $68.75M+5.6% | $52.47M+10.6% | $50.42M+2.7% | $68.3M+23.5% | |
| Total Assets by Business | ||||||
| Prevention & Recovery | $1.45B— | $1.47B— | —— | —— | —— | |
| Reconstructive | $2.38B-19.9% | $2.36B-14.6% | $2.66B— | $3.08B— | $2.98B— | |
| Other Cost and Expense, Operating by Business | ||||||
| Prevention & Recovery | $112.47M+4.3% | —— | —— | —— | $107.84M— | |
| Reconstructive | $149.28M+7.9% | $131.14M+2.3% | $128.26M+8.5% | $134.74M+6.3% | $138.4M+11.3% | |
| Operating Costs and Expenses by Business | ||||||
| Prevention & Recovery | $245.97M+0.1% | —— | —— | —— | $245.85M— | |
| Reconstructive | $270.4M+6.1% | $248.48M+6.4% | $231.22M+11.8% | $247.51M+11.6% | $254.97M+13.5% | |
| Segment, Expenditure, Addition to Long-Lived Assets by Business | ||||||
| Prevention & Recovery | $7.2M-18.1% | —— | —— | —— | $8.79M— | |
| Reconstructive | $45.6M+32.3% | —— | $46.63M+16.1% | $38.83M+13.4% | $34.47M— | |
| Cost of Goods and Services Sold by Business | ||||||
| Prevention & Recovery | $125.76M-2.3% | —— | —— | —— | $128.76M— | |
| Reconstructive | $97.34M+0.1% | $94.49M+5.0% | $82.86M+7.3% | $91.75M+13.6% | $97.28M+13.6% | |
| Depreciation by Business | ||||||
| Prevention & Recovery | $5.07M+21.5% | —— | —— | —— | $4.17M— | |
| Reconstructive | $25.73M+3.5% | $771.01M+80.2% | $25.71M+10.6% | $23.96M+2.4% | $24.87M+10.0% | |
| Research and development expense by Business | ||||||
| Prevention & Recovery | $7.75M-16.2% | —— | —— | —— | $9.24M— | |
| Reconstructive | $23.79M+23.3% | $22.85M+49.2% | $20.1M+76.3% | $21.03M+47.7% | $19.29M+32.1% | |
| Provisions by Business | ||||||
| Prevention & Recovery | $1.4M— | —— | —— | —— | —— | |
| Reconstructive | $1.3M+30.0% | $5.8M-59.2% | $2.9M+38.1% | $300K-89.7% | $1M-80.4% | |
| Net Sales by Product | ||||||
| Bracing and Support | $114.88M-0.2% | $123.32M-0.7% | $126.98M+3.2% | $120.85M+2.8% | $115.09M+10.1% | |
| Other Prevention and Recovery | $55.86M-16.2% | $62.78M-10.6% | $71.41M+7.9% | $70.82M+4.2% | $66.62M+0.4% | |
| Surgical | $317.13M+10.8% | $292.88M+6.9% | $257.97M+11.7% | $273.98M+10.7% | $286.25M+11.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Enovis break its business down?
- Enovis (ENOV) reports net sales by business across 2 parts — Prevention & Recovery and Reconstructive. Each is extracted from the segment footnotes and tracked over time.
- Where does Enovis's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Enovis's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
